All podcasts

A Non-Profit Biotech Model; Therapies for Rare Diseases - Dr. Ashley Winslow

Sep 9, 2023 by Dr. Kevin Folta in Talking Biotech

Apple podcasts linkGoogle podcasts linkSpotify podcasts link

This episode has two parts. The first part discusses how Odylia Therapeutics is addressing rare disease, using a novel non-profit model. The second half address two rare genetic eye diseases and the approaches being designed to address them. Dr. Ashley Winslow, CEO/CSO of Odylia, describes how a non-profit is well suited to address these rare diseases, using strategies that leverage capacities in rare disease patient communities coupled to their expertise in drug discovery.


Get your whole lab on the same page today.

Learn more